Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous Anti-D for ITP in Children
NCT00128882Phase 2Completed
- Sponsor
- Aarhus University
- Start
- Nov 2004
- Primary completion
- Jan 2008
- Modality
- Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of rho(d) immune globulin in immune thrombocytopenia (ITP), sponsored by Aarhus University. Primary endpoint: Clinical effect evaluated on clinical score scale at Day 360. Started Nov 2004; status: completed.
02
Drugs
rho(d) immune globulin
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT00128882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00128882.